EUVIMEDAvasta EUVIMED
Fallbericht

Double Filtration Plasmapheresis for Refractory Hypercholesterolemia in Drug‐Induced Cholestasis: A Case Report

Yuling Liang, Wenjian Zhu, Dandan Yang, Zhihua Zheng, Xiaohua Wang, Yan Lei

Journal of Clinical Apheresis · 2026-04 · 41 (2)

DOI: 10.1002/jca.70117 ↗

At a glance

Fallbericht in Journal of Clinical Apheresis, published online on 2026-03-27. Written by Yuling Liang and 5 co-authors. Institution: Department of Nephrology, Center of Nephrology and Urology, the Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China. Major MEDLINE topics: Hypercholesterolemia, Plasmapheresis, Cholestasis. 15 references. Funded by: the Hospital Research Fund of SAHSYSU, the Seventh Affiliated Hospital, Sun Yat-sen University Clinical Research 735 Program, Sanming Project of Medicine in Shenzen Municipality.

AbstraktSubjectsBibliograafilised andmedCiteRelated studies

Abstract (original language)

While lipoprotein apheresis (LA) is established for lipid management in primary biliary cholangitis, the role of apheresis techniques in drug‐induced cholestatic liver disease remains unexplored. We report the novel application of double filtration plasmapheresis (DFPP) for rapid reversal of severe hypercholesterolemia in iatrogenic cholestasis, where conventional therapies failed or were contraindicated. A 56‐year‐old male developed severe cholestatic hepatitis following the use of herbal agents. Laboratory investigation revealed extreme hypercholesterolemia, with a total cholesterol (TC) of 41.39 mmol/L and a low‐density lipoprotein cholesterol (LDL‐c) of 38 mmol/L. Standard medical therapy proved ineffective. Two sessions of DFPP resulted in > 90% reduction in cholesterol levels and simultaneous improvement in bilirubin and liver enzymes, with sustained normal levels at 1‐year follow‐up. DFPP may serve as a novel rescue therapy for drug‐induced cholestatic hypercholesterolemia, providing simultaneous removal of cholesterol and bilirubin where other treatments are ineffective or at high risk.

Subjects

MeSH terms (MEDLINE)

HypercholesterolemiaPlasmapheresisCholestasisHumansMiddle AgedMaleFiltrationBilirubin

Author keywords

apheresis techniquescase reportdouble filtration plasmapheresisdrug‐induced cholestasisrefractory hypercholesterolemia

Substances

Bilirubin

Authors and institutions

  • Department of Nephrology, Center of Nephrology and Urology, the Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China.

Funding

  • the Hospital Research Fund of SAHSYSU
  • the Seventh Affiliated Hospital, Sun Yat-sen University Clinical Research 735 Program
  • Sanming Project of Medicine in Shenzen Municipality

Cite

APA

Liang, Y., Zhu, W., Yang, D., Zheng, Z., Wang, X., & Lei, Y. (2026). Double Filtration Plasmapheresis for Refractory Hypercholesterolemia in Drug‐Induced Cholestasis: A Case Report. Journal of Clinical Apheresis, 41(2). https://doi.org/10.1002/jca.70117

Vancouver

Liang Y, Zhu W, Yang D, Zheng Z, Wang X, Lei Y. Double Filtration Plasmapheresis for Refractory Hypercholesterolemia in Drug‐Induced Cholestasis: A Case Report. Journal of Clinical Apheresis. 2026;41(2). doi:10.1002/jca.70117

BibTeX
@article{Liang2026,
  author = {Liang, Yuling and Zhu, Wenjian and Yang, Dandan and Zheng, Zhihua and Wang, Xiaohua and Lei, Yan},
  title = {Double Filtration Plasmapheresis for Refractory Hypercholesterolemia in Drug‐Induced Cholestasis: A Case Report},
  journal = {Journal of Clinical Apheresis},
  year = {2026},
  volume = {41},
  number = {2},
  doi = {10.1002/jca.70117}
}
Start for free →